New Infographic Highlights Growth of Presbyopia and Other Age-Related Visual Impairments and Impact on Workplace Productivity, Economy

Addressing age-related visual impairments, like presbyopia, is an increasingly important and achievable policy priority as the oldest Millennials reach middle age.

New York, NEW YORK (March 15, 2022)—The Global Coalition on Aging (GCOA) today published an infographic, Vision Health and the Future of Work: An Underrecognized Priority for Governments and Employers in the 21stCentury, highlighting the growing importance of preventing avoidable visual impairments and the cascading consequences across healthcare and the 21st century workplace should visual impairments remain unaddressed. The infographic was created in partnership with the International Agency for the Prevention of Blindness (IAPB).

Globally, 2.2 billion people are living with a vision impairment, and 1 billion of these cases were either left untreated or were entirely avoidable. As our population ages, preventable visual impairment is growing in prevalence. By 2050, the number of people over 65 will almost double, from 1 in 11 to 1 in 6 people. Presbyopia is a commonly unaddressed visual impairment that often begins around age 40, when people are in the prime of their working lives. It is estimated that 510 million people cannot see well at near distances.

“Presbyopia offers an important example of where we can be doing. more. It’s widely underrecognized, in part due to ageism, yet it affects an individual’s ability to carry out a range of near vision activities—from hobbies, to mobile phone usage, to the sorts of precision tasks required in the workplace, impacting office workers and trade workers alike, with impacts starting much earlier than most people realize,” explained Mike Hodin, CEO of the Global Coalition on Aging.

The loss of productivity from presbyopia and other visual impairments will become even more consequential as the Millennial generation, the largest global generation, reaches age 40 and more older adults continue to work past traditional retirement age.

Already an estimated one-third of workers worldwide have some form of unaddressed visual impairment in need of correction, and costs due to vision loss are expected to grow as the population ages. In 2019, the U.S. spent $168 billion on direct medical costs alone for visual impairment and loss, a figure that is expected to reach $717 billion by 2050.

The infographic calls for multiple levels of action to address avoidable age-related visual impairments through:

  • greater action by policymakers and employers to support employee vision health,
  • increased employee awareness of their own vision health and the importance of prevention, early diagnosis and care,
  • further research on the impacts of age-related visual impairments on employee productivity, participation, and quality of life.


Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.